NCT06562647 2026-02-13
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Cell Origin Biotech (Hangzhou) Co., Ltd.
Phase NA Recruiting
Cell Origin Biotech (Hangzhou) Co., Ltd.
Hospital del Mar
Chang Gung Memorial Hospital
Rigshospitalet, Denmark
Soonchunhyang University Hospital
Selcuk University